Among these, four were anti-IPF drug target genes: tumor necrosis factor (TNF), C-C motif chemokine (CCL2), interleukin-6 (IL6), and interleukin-10 (IL10). This evidence concerns the gene TNF and idiopathic pulmonary fibrosis.